Peer-reviewedCC BYJournal of translational internal medicine
Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition
- 1Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Related
- Prognostic Value of Serial Alkaline Phosphatase-to-Albumin Ratio for Mortality After Transjugular Intrahepatic Portosystemic Shunt
- Early Prognostic Value of the Freiburg Index of Post-Transjugular Intrahepatic Portosystemic Shunt Survival in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation
- Clot Out, Flow Back: Large-Bore Aspiration Thrombectomy for Symptomatic Early Transjugular Intrahepatic Portosystemic Shunt (TIPS) Occlusion.
- Reevaluating hypercoagulability in the portal vein and the impact of transjugular intrahepatic portosystemic shunt on platelet activation in cirrhosis
- Inhibition of the ZEB1–BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma
BibTeX
@article{ye2026dualpathway,
title = {{Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition}},
author = {Yanting Ye and Zhiyin Huang and Jinhang Gao and Chengwei Tang},
journal = {Journal of translational internal medicine},
year = {2026},
month = aug,
doi = {10.1515/jtim-2026-0077},
url = {https://europepmc.org/article/PMC/PMC13726661},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition
AU - Yanting Ye
AU - Zhiyin Huang
AU - Jinhang Gao
AU - Chengwei Tang
PY - 2026
DA - 2026/08/24
JO - Journal of translational internal medicine
DO - 10.1515/jtim-2026-0077
UR - https://europepmc.org/article/PMC/PMC13726661
SN - 2450-131X
SN - 2224-4018
ER -